our results demonstrate a close link between effective intracellular uptake of the drug delivery system and its therapeutic outcome.
The sulfatide-containing liposomes (SCL) may represent an interesting ligand-targeted drug carrier for a wide spectrum of cancers in which sulfatide-binding ECM glycoproteins are expressed.